Related Experiment Videos

Cytokines in inflammatory bowel disease

J Brynskov¹, O H Nielsen, I Ahnfelt-Rønne

¹Dept. of Medical Gastroenterology C, Herlev Hospital, University of Copenhagen, Denmark.

Scandinavian Journal of Gastroenterology

|November 1, 1992

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Pre-existing IgG antibodies cross-reacting with the Fab region of infliximab predict efficacy and safety of infliximab therapy in inflammatory bowel disease.

Alimentary pharmacology & therapeutics·2013

Gram-negative bacteria account for main differences between faecal microbiota from patients with ulcerative colitis and healthy controls.

Beneficial microbes·2012

Genetic polymorphisms of tumour necrosis factor receptor superfamily 1b and fas ligand are associated with clinical efficacy and/or acute severe infusion reactions to infliximab in Crohn's disease.

Alimentary pharmacology & therapeutics·2012

Severe infusion reactions to infliximab: aetiology, immunogenicity and risk factors in patients with inflammatory bowel disease.

Alimentary pharmacology & therapeutics·2011

Spontaneous and cytokine induced expression and activity of matrix metalloproteinases in human colonic epithelium.

Clinical and experimental immunology·2009

Methylprednisolone does not restore biological response in multiple sclerosis patients with neutralizing antibodies against interferon-β.

European journal of neurology·2008

See all related articles